175 related articles for article (PubMed ID: 2653244)
1. Selective depletion and activation of CD8+ lymphocytes from peripheral blood of patients with polymyalgia rheumatica and giant cell arteritis.
Dasgupta B; Duke O; Timms AM; Pitzalis C; Panayi GS
Ann Rheum Dis; 1989 Apr; 48(4):307-11. PubMed ID: 2653244
[TBL] [Abstract][Full Text] [Related]
2. Circulating T cell subtypes in polymyalgia rheumatica and giant cell arteritis: variation in the percentage of CD8+ cells with prednisolone treatment.
Pountain GD; Keogan MT; Brown DL; Hazleman BL
Ann Rheum Dis; 1993 Oct; 52(10):730-3. PubMed ID: 8257209
[TBL] [Abstract][Full Text] [Related]
3. Lymphocyte subpopulations analysis in peripheral blood in polymyalgia rheumatica/giant cell arteritis.
Macchioni P; Boiardi L; Salvarani C; Rossi F; Casadei-Maldini M; Mancini R; Beltrandi E; Portioli I
Br J Rheumatol; 1993 Aug; 32(8):666-70. PubMed ID: 8348267
[TBL] [Abstract][Full Text] [Related]
4. Selective T cell receptor decrease in peripheral blood T lymphocytes of patients with polymyalgia rheumatica and giant cell arteritis.
Lopez-Hoyos M; Bartolome-Pacheco MJ; Blanco R; Rodriguez-Valverde V; Martinez-Taboada VM
Ann Rheum Dis; 2004 Jan; 63(1):54-60. PubMed ID: 14672892
[TBL] [Abstract][Full Text] [Related]
5. The sensitivity and specificity of reduced CD8 lymphocyte levels in the diagnosis of polymyalgia rheumatica/giant cell arteritis.
Arnold MH; Corrigall VM; Pitzalis C; Panayi GS
Clin Exp Rheumatol; 1993; 11(6):629-34. PubMed ID: 8299254
[TBL] [Abstract][Full Text] [Related]
6. Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review.
Martinez-Taboada VM; Blanco R; Fito C; Pacheco MJ; Delgado-Rodriguez M; Rodriguez-Valverde V
Semin Arthritis Rheum; 2001 Feb; 30(4):257-71. PubMed ID: 11182026
[TBL] [Abstract][Full Text] [Related]
7. Serum immunoglobulin G4 in giant cell arteritis and polymyalgia rheumatica.
Burkel M; Arndt F; Schirmer JH; Moosig F; Holle JU
Clin Exp Rheumatol; 2017; 35 Suppl 103(1):94-97. PubMed ID: 27974093
[TBL] [Abstract][Full Text] [Related]
8. A genetic approach to the aetiology of giant cell arteritis: depletion of the CD8+ T-lymphocyte subset in relatives of patients with polymyalgia rheumatica and arteritis temporalis.
Johansen M; Elling P; Elling H; Olsson A
Clin Exp Rheumatol; 1995; 13(6):745-8. PubMed ID: 8835249
[TBL] [Abstract][Full Text] [Related]
9. Familial aggregation of polymyalgia rheumatica and giant cell arteritis: genetic and T cell repertoire analysis.
Bartolome MJ; Martínez-Taboda VM; Lopez-Hoyos M; Blanco R; Rodriguez-Valverde V
Clin Exp Rheumatol; 2001; 19(3):259-64. PubMed ID: 11407077
[TBL] [Abstract][Full Text] [Related]
10. Lymphocyte subpopulations analysis in peripheral blood in polymyalgia rheumatica/giant cell arteritis.
Pountain G; Keogan M; Hazleman B; Brown D
Br J Rheumatol; 1994 Feb; 33(2):194-5. PubMed ID: 8162492
[No Abstract] [Full Text] [Related]
11. Role of peripheral CD8 lymphocytes and soluble IL-2 receptor in predicting the duration of corticosteroid treatment in polymyalgia rheumatica and giant cell arteritis.
Salvarani C; Boiardi L; Macchioni P; Rossi F; Tartoni P; Casadei Maldini M; Mancini R; Beltrandi E; Portioli I
Ann Rheum Dis; 1995 Aug; 54(8):640-4. PubMed ID: 7677440
[TBL] [Abstract][Full Text] [Related]
12. CD8+ lymphocyte subset in polymyalgia rheumatica and arteritis temporalis. Inverse relationship between the acute hepatic phase reactants and the CD8+ T-cell subset.
Elling H; Elling P; Olsson A
Clin Exp Rheumatol; 1989; 7(6):627-30. PubMed ID: 2533002
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-6 in serum of patients with polymyalgia rheumatica and giant cell arteritis.
Dasgupta B; Panayi GS
Br J Rheumatol; 1990 Dec; 29(6):456-8. PubMed ID: 2124160
[TBL] [Abstract][Full Text] [Related]
14. NKG2D stimulated T-cell autoreactivity in giant cell arteritis and polymyalgia rheumatica.
Dejaco C; Duftner C; Al-Massad J; Wagner AD; Park JK; Fessler J; Aigelsreiter A; Hafner F; Vega S; Sterlacci W; Grubeck-Loebenstein B; Tzankov A; Ness T; Boiardi L; Salvarani C; Schirmer M
Ann Rheum Dis; 2013 Nov; 72(11):1852-9. PubMed ID: 23417963
[TBL] [Abstract][Full Text] [Related]
15. A longitudinal study of anticardiolipin antibody in polymyalgia rheumatica and giant cell arteritis.
Chakravarty K; Pountain G; Merry P; Byron M; Hazleman B; Scott DG
J Rheumatol; 1995 Sep; 22(9):1694-7. PubMed ID: 8523347
[TBL] [Abstract][Full Text] [Related]
16. Homocysteine levels in polymyalgia rheumatica and giant cell arteritis: influence of corticosteroid therapy.
Martinez-Taboada VM; Bartolome MJ; Fernandez-Gonzalez MD; Blanco R; Rodriguez-Valverde V; Lopez-Hoyos M
Rheumatology (Oxford); 2003 Sep; 42(9):1055-61. PubMed ID: 12730520
[TBL] [Abstract][Full Text] [Related]
17. Treatment of polymyalgia rheumatica and giant cell arteritis. I. Steroid regimens in the first two months.
Kyle V; Hazleman BL
Ann Rheum Dis; 1989 Aug; 48(8):658-61. PubMed ID: 2782975
[TBL] [Abstract][Full Text] [Related]
18. Plasma adrenomedullin levels in patients with polymyalgia rheumatica and giant cell arteritis.
Garcia-Unzueta MT; Martínez-Taboada VM; Amado-Señarís JA; Rodríguez-Valverde V
Clin Exp Rheumatol; 2006; 24(2 Suppl 41):S6-9. PubMed ID: 16859588
[TBL] [Abstract][Full Text] [Related]
19. Lack of consistent peripheral blood lymphocyte transformation responses in polymyalgia rheumatica and giant cell arteritis.
Jones JG; Park JR; Hazelman BL; Ward M; Bulgen DY
J Rheumatol; 1980; 7(6):891-4. PubMed ID: 7205827
[TBL] [Abstract][Full Text] [Related]
20. [Polymyalgia rheumatica and giant cell arteritis--first results of a year-long study].
Rovenský J; Tuchynová A; Poprac P; Blazíková S; Bosák V; Stvrtinová V
Vnitr Lek; 2006; 52(7-8):691-6. PubMed ID: 16967610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
